Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px
Collaboration › Details

Argen-X–Leucadia: investor conference, 201506 supply service Argen-X presents at Jefferies Global Healthcare Conference New York


Period Period 2015-06-02
  Successor Argen-X–Leucadia: investor conference, 201511 supply service Argenx participates in Jefferies Global Healthcare Conference London
Organisations Partner, 1st Argen-X N.V. (Argenx) (Euronext + Nasdaq: ARGX)
  Today Argenx SE (Euronext + Nasdaq: ARGX)
  Group Argenx (Argen-X) (Group)
  Partner, 2nd Jefferies LLC
  Group Leucadia (Group)
Products Product Jefferies 2015 Global Healthcare Conference New York
  Product 2 antibody cancer drug
Person Person Van Hauwermeiren, Tim (Argen-X 201101 CEO before Ablynx BusDev Manager before P&G)

Argen-X N.V. (Argenx). (6/1/15). "Press Release: Argen-X to Present at Jefferies 2015 Global Healthcare Conference on Tuesday, 2 June at 8:00am EDT". Breda & Ghent.

arGEN-X N.V. (Euronext Brussels: ARGX), a clinical-stage biopharmaceutical company focused on creating and developing differentiated therapeutic antibodies for the treatment of cancer and severe autoimmune diseases, today announced that Chief Executive Officer, Tim Van Hauwermeiren, will present a corporate update at the Jefferies 2015 Global Healthcare Conference in New York City (NY, USA) on Tuesday, 2 June 2015 at 8:00am EDT.

The presentation will be webcast live and can be accessed on the day via this link. A replay of the webcast will be available on the Company’s website, under the Reports & Presentations section, for 90 days following the presentation. To ensure a timely connection, it is recommended that users register at least 10 minutes prior to the scheduled webcast.

arGEN-X N.V.
Breda, The Netherlands
T +31 763 030 488

argenx BVBA
Zwijnaarde, Belgium
T +32 9 243 40 70

Record changed: 2016-11-27


Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

More documents for Argenx (Argen-X) (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [LSUS] – The Business Web Portal 600x60px

» top